
### [NCIT:C2895](http://purl.obolibrary.org/obo/NCIT_C2895)
**Label:** Benign Ovarian Neoplasm

**Subclasses:** [NCIT:C4516](http://purl.obolibrary.org/obo/NCIT_C4516) (Benign Ovarian Germ Cell Tumor), [NCIT:C4510](http://purl.obolibrary.org/obo/NCIT_C4510) (Benign Ovarian Epithelial Tumor), [NCIT:C4511](http://purl.obolibrary.org/obo/NCIT_C4511) (Ovarian Serous Cystadenoma), [NCIT:C4512](http://purl.obolibrary.org/obo/NCIT_C4512) (Ovarian Mucinous Cystadenoma), [NCIT:C121953](http://purl.obolibrary.org/obo/NCIT_C121953) (Ovarian Microcystic Stromal Tumor), [NCIT:C7291](http://purl.obolibrary.org/obo/NCIT_C7291) (Ovarian Cellular Fibroma), [NCIT:C4060](http://purl.obolibrary.org/obo/NCIT_C4060) (Ovarian Cystadenoma), [NCIT:C40087](http://purl.obolibrary.org/obo/NCIT_C40087) (Benign Ovarian Transitional Cell Tumor), [NCIT:C40085](http://purl.obolibrary.org/obo/NCIT_C40085) (Ovarian Clear Cell Adenofibroma), [NCIT:C40041](http://purl.obolibrary.org/obo/NCIT_C40041) (Ovarian Mucinous Cystadenofibroma), [NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma), [NCIT:C40040](http://purl.obolibrary.org/obo/NCIT_C40040) (Ovarian Mucinous Adenofibroma), [NCIT:C40084](http://purl.obolibrary.org/obo/NCIT_C40084) (Benign Ovarian Clear Cell Tumor), [NCIT:C27288](http://purl.obolibrary.org/obo/NCIT_C27288) (Ovarian Endometrioid Cystadenofibroma), [NCIT:C3498](http://purl.obolibrary.org/obo/NCIT_C3498) (Ovarian Fibroma), [NCIT:C4746](http://purl.obolibrary.org/obo/NCIT_C4746) (Benign Ovarian Brenner Tumor), [NCIT:C6803](http://purl.obolibrary.org/obo/NCIT_C6803) (Benign Ovarian Sex Cord-Stromal Tumor), [NCIT:C27287](http://purl.obolibrary.org/obo/NCIT_C27287) (Ovarian Endometrioid Adenofibroma), [NCIT:C7278](http://purl.obolibrary.org/obo/NCIT_C7278) (Ovarian Papillary Cystadenoma), [NCIT:C7313](http://purl.obolibrary.org/obo/NCIT_C7313) (Benign Ovarian Serous Tumor), [NCIT:C7279](http://purl.obolibrary.org/obo/NCIT_C7279) (Ovarian Surface Papilloma), [NCIT:C40039](http://purl.obolibrary.org/obo/NCIT_C40039) (Benign Ovarian Mucinous Tumor), [NCIT:C7282](http://purl.obolibrary.org/obo/NCIT_C7282) (Benign Ovarian Seromucinous Tumor), [NCIT:C40032](http://purl.obolibrary.org/obo/NCIT_C40032) (Ovarian Serous Cystadenofibroma), [NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma), [NCIT:C40031](http://purl.obolibrary.org/obo/NCIT_C40031) (Ovarian Serous Adenofibroma), [NCIT:C40072](http://purl.obolibrary.org/obo/NCIT_C40072) (Benign Ovarian Endometrioid Tumor), [NCIT:C126331](http://purl.obolibrary.org/obo/NCIT_C126331) (Ovarian Adenomatoid Tumor), [NCIT:C126311](http://purl.obolibrary.org/obo/NCIT_C126311) (Ovarian Seromucinous Adenofibroma), [NCIT:C126310](http://purl.obolibrary.org/obo/NCIT_C126310) (Ovarian Seromucinous Cystadenoma), 

**Class expressions from DL-Learner:**

- [NCIT:C41457](http://purl.obolibrary.org/obo/NCIT_C41457) (Well-Circumscribed Lesion) 54.17%
- [NCIT:C36116](http://purl.obolibrary.org/obo/NCIT_C36116) (Borderline Lesion) 54.17%
- [NCIT:C26945](http://purl.obolibrary.org/obo/NCIT_C26945) (Vaginal Hemorrhage) 54.17%
- Thing 52.82%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) 39.52%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39056](http://purl.obolibrary.org/obo/NCIT_C39056) (Vesicle Transport Pathway))) 39.52%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39055](http://purl.obolibrary.org/obo/NCIT_C39055) (Phospholipid Signaling Pathway))) 39.52%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39054](http://purl.obolibrary.org/obo/NCIT_C39054) (Extracellular Matrix Binding Pathway))) 39.52%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39040](http://purl.obolibrary.org/obo/NCIT_C39040) (CTCF Pathway))) 39.52%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39021](http://purl.obolibrary.org/obo/NCIT_C39021) (Cell Migration Pathway))) 39.52%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39016](http://purl.obolibrary.org/obo/NCIT_C39016) (EGF Receptor Downregulation by CBL Pathway))) 39.52%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39013](http://purl.obolibrary.org/obo/NCIT_C39013) (Estrogen Receptor Regulation by CARM1 Pathway))) 39.52%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39011](http://purl.obolibrary.org/obo/NCIT_C39011) (Cardiac Hypertrophy Pathway))) 39.52%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C3901](http://purl.obolibrary.org/obo/NCIT_C3901) (Compound Nevus))) 39.52%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39006](http://purl.obolibrary.org/obo/NCIT_C39006) (Bioactive Peptide Signaling Pathway))) 39.52%


